Intelligencia is a proprietary AI platform designed to optimize drug development processes. By utilizing machine learning algorithms and data analytics, it provides pharmaceutical companies with detailed insights, helping them make confident business decisions. The platform focuses on reducing risks, improving clinical development strategies, and providing real-time data-driven results for better decision-making. Its AI technology assesses competitive landscapes and identifies promising assets, making it an essential tool for enhancing drug development outcomes.

DoubleCloud offers a robust, no-code data integration and analytics platform, designed for modern organizations seeking real-time data analysis and infrastructure solutions. The platform enables users to build a complete data analytics infrastructure in a single day, streamlining data pipelines with zero maintenance using open-source technologies like ClickHouse, Kafka, and Airflow. By utilizing DoubleCloud, organizations can save time and costs while focusing on building insights from their data.